Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingolf Cascorbi

Showing results (41-50 of 192) with videos related to

Pageof 20
Sort By:
BMJ (Clinical Research Ed.)|December 17, 2008
Regulation's threat to research. A UK problemIngolf Cascorbi, Michael Orme, John R Cockroft, et al.
Pharmacogenomics|July 27, 2011
Clinical implementation of pharmacogenetics: a nonrepresentative explorative survey to participants of WorldPharma 2010Fatima Ghaddar, Ingolf Cascorbi, Nathalie K Zgheib
British Journal of Clinical Pharmacology|March 21, 2014
MicroRNAs and their relevance to ABC transportersSierk Haenisch, Anneke Nina Werk, Ingolf Cascorbi
Veterinary Research|September 6, 2011
Antimicrobial peptides and proteins of the horse--insights into a well-armed organismOliver Bruhn, Joachim Grötzinger, Ingolf Cascorbi, et al.
Deutsches Arzteblatt International|August 24, 2018
Drug HypersensitivityRuwen Böhm, Ehrhardt Proksch, Thomas Schwarz, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 11, 2005
A LC-MS/MS method to quantify the novel cholesterol lowering drug ezetimibe in human serum, urine and feces in healthy subjects genotyped for SLCO1B1Stefan Oswald, Eberhard Scheuch, Ingolf Cascorbi, et al.
Deutsches Arzteblatt International|November 28, 2018
In ReplyRuwen Böhm, Ingolf Cascorbi, Ehrhardt Proksch, et al.
Molecular Pharmaceutics|March 17, 2021
Interaction of Phytocompounds of <i>Echinacea purpurea</i> with ABCB1 and ABCG2 Efflux TransportersCharles Awortwe, Henrike Bruckmueller, Meike Kaehler, et al.
Nature Biotechnology|February 10, 2012
OpenVigil--free eyeballs on AERS pharmacovigilance dataRuwen Böhm, Jan Höcker, Ingolf Cascorbi, et al.
BMC Cancer|June 19, 2025
The MAP kinase negative regulator DUSP2 (dual specificity phosphatase 2) is controlled by oncogenic microRNA cluster miR-17-92, miR-106a-363 and miR-106b-25Victoria Tenhaken, Ole-Morten Seternes, Ingolf Cascorbi, et al.
Pageof 20

Showing results (41-50 of 192) with videos related to

Sort By:
Pageof 20
BMJ (Clinical Research Ed.)|December 17, 2008
Regulation's threat to research. A UK problemIngolf Cascorbi, Michael Orme, John R Cockroft, et al.
Pharmacogenomics|July 27, 2011
Clinical implementation of pharmacogenetics: a nonrepresentative explorative survey to participants of WorldPharma 2010Fatima Ghaddar, Ingolf Cascorbi, Nathalie K Zgheib
British Journal of Clinical Pharmacology|March 21, 2014
MicroRNAs and their relevance to ABC transportersSierk Haenisch, Anneke Nina Werk, Ingolf Cascorbi
Veterinary Research|September 6, 2011
Antimicrobial peptides and proteins of the horse--insights into a well-armed organismOliver Bruhn, Joachim Grötzinger, Ingolf Cascorbi, et al.
Deutsches Arzteblatt International|August 24, 2018
Drug HypersensitivityRuwen Böhm, Ehrhardt Proksch, Thomas Schwarz, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 11, 2005
A LC-MS/MS method to quantify the novel cholesterol lowering drug ezetimibe in human serum, urine and feces in healthy subjects genotyped for SLCO1B1Stefan Oswald, Eberhard Scheuch, Ingolf Cascorbi, et al.
Deutsches Arzteblatt International|November 28, 2018
In ReplyRuwen Böhm, Ingolf Cascorbi, Ehrhardt Proksch, et al.
Molecular Pharmaceutics|March 17, 2021
Interaction of Phytocompounds of <i>Echinacea purpurea</i> with ABCB1 and ABCG2 Efflux TransportersCharles Awortwe, Henrike Bruckmueller, Meike Kaehler, et al.
Nature Biotechnology|February 10, 2012
OpenVigil--free eyeballs on AERS pharmacovigilance dataRuwen Böhm, Jan Höcker, Ingolf Cascorbi, et al.
BMC Cancer|June 19, 2025
The MAP kinase negative regulator DUSP2 (dual specificity phosphatase 2) is controlled by oncogenic microRNA cluster miR-17-92, miR-106a-363 and miR-106b-25Victoria Tenhaken, Ole-Morten Seternes, Ingolf Cascorbi, et al.
Pageof 20